CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Pres and CEO gave up 9,125 shares (to pay taxes)
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $5.08 ($30,460)
- 4 Open-market buy Chief Financial Officer bought 9,490 shares at $7.90 ($74,971)
- 4 Shares withheld for taxes Chief Financial Officer gave up 285 shares (to pay taxes)
- 4 Open-market buy Chief Business Officer bought 14,705 shares at $6.80 ($99,959)
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $7.32 ($43,895)
- 4 Shares withheld for taxes Pres and CEO gave up 4,437 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,407 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 16,500 shares (option exercise)
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $10.28 ($61,663)
- 4 Exercise or conversion Director acquired 249 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,507 shares (option exercise)
- 4 Open-market buy Pres and CEO bought 6,300 shares at $7.86 ($49,532)
Page 6 of 21 · 414 filings